CATB News and Press, Catabasis Pharmaceuticals Inc. From 12/02/20

Gainers: NanoVibronix (NAOV) +99%.Merrimack Pharmaceuticals (MACK) +46%.Catabasis Pharmaceuticals (CATB) +44%.Tredegar (TG) +27%.Intec Pharma (NTEC) +27%.Kingsway Financial Services (KFS) +25%.Sequential Brands (SQBG) +23%.Sequans Communications (SQNS) +20%.Mmtec (MTC) +20%.Callon Petrol...

Gainers: Catabasis Pharmaceuticals (CATB) +44%, iBio (IBIO) +21%, Cellectar Biosciences (CLRB) +21%, Intec Pharma (NTEC) +18%, Sio Gene Therapies (SIOX) +18%.Losers: Ovid Therapeutics (OVID) -55%, Auris Medical (EARS) -35%, iRhythm Techno...

Tredegar Corporation (TG +29% on declaring special dividend.Catabasis Pharmaceuticals (CATB) +25%.India Globalization Capital (IGC) +19%.Ashford Hospitality Trust (AHT) +14%.Mesoblast Limited (MESO) +12%.iBio (IBIO +12% after company was selected to produce ATB Therapeutic...

4 Biotech Penny Stocks To Watch Right Now Biotech stocks and penny stocks go hand-in-hand in many ways. One of the clearest is how speculation tends to drive momentum. Much like penny stocks, traders speculate on what potential outcomes may be during different phase trials that comp...

Catabasis Pharmaceuticals (CATB): Q3 GAAP EPS of -$0.56. Cash, equivalents and short-term investments of $52.9M.Press Release For further details see: Catabasis Pharmaceuticals reports Q3 results

-- Cash and Cash Equivalents Totaled $52.9 Million as of September 30, 2020 -- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2020 and provided a corporate update. ...

Catabasis failed a Phase 3 Duchenne Muscular Dystrophy trial. Revolution Medicines reports anti-tumor activity for RMC-4630. Novartis reports positive data for iptacopan in C3 glomerulopathy. For further details see: Catabasis' Catastrophic Failure, And Other News: The G...

Neovasc NVCN -38% as FDA Ad Com thumbs down on Neovasc Reducer.Akerna (KERN) -16%.Six Flags Entertainment SIX -11% on Q3 earnings release.Bed Bath & Beyond BBBY -10% on announcing buyback activity after selling assets.Big 5 Sporting Goods BGFV -9% o...

Gainers: Scholar Rock (SRRK) +87%.Weidai (WEI) +60%.1847 Goedeker (GOED) +43%.Harley-Davidson (HOG) +27%.Synalloy (SYNL) +25%.Exact Sciences (EXAS) +22%.Harbor Custom Development (HCDI) +21%.TuanChe (TC) +20%.Unifi (UFI) +19%.CASI Pharmaceuticals (CASI) +18%.Losers: Cataba...

Gainers: Scholar Rock Holding (SRRK) +80%, Exact Sciences (EXAS) +18%, CHF Solutions (CHFS) +17%, CASI Pharmaceuticals (CASI) +13%, Prelude Therapeutics (PRLD) +8%.Losers: Catabasis Pharmaceuticals (CATB) -68%, Galera Therapeutics (GRTX)&...